From: PECAM-1 drives β-catenin-mediated EndMT via internalization in colon cancer with diabetes mellitus
Parameters | Colon cancer (n = 84) | Colon cancer with DM (n = 108) | Total (n = 192) | P-value |
---|---|---|---|---|
Gender | 0.307 | |||
Male | 49 | 55 | 104 | |
Female | 35 | 53 | 88 | |
Age | 0.300 | |||
≤ 55 | 29 | 28 | 57 | |
> 55 | 55 | 80 | 135 | |
T stage | 0.368 | |||
T1 | 1 | 5 | 6 | |
T2 | 4 | 5 | 9 | |
T3 | 73 | 93 | 166 | |
T4 | 2 | 4 | 5 | |
Tx | 4 | 2 | 6 | |
N stage | 0.016* | |||
N0 | 59 | 61 | 120 | |
N1 | 15 | 35 | 50 | |
N2 | 4 | 12 | 16 | |
Nx | 6 | 0 | 6 | |
M stage | ||||
M0 | 83 | 108 | 192 | |
Survival time | 0.004* | |||
≤ 70 months | 16 | 41 | 57 | |
> 70 months | 68 | 67 | 135 |